BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• ASCO15: Cantex Pharmaceuticals Announces Poster Presentation At ASCO 2015 Indicating Potential Efficacy Of CX-01

  June 1, 2015

   · 

  3 min read
• Drug Development

  ASCO15: Data Presentations At ASCO Demonstrate The Ability Of Peregrine Pharmaceuticals, Inc.’ Bavituximab To Activate Tumor Targeting Immune Cells In PD-L1 Negative NSCLC Tumors

  June 1, 2015

   · 

  8 min read
• Drug Development

  ASCO15: Aduro Biotech Announces ASCO Presentation Of Encouraging Data From Ongoing Phase Ib Clinical Trial Of Its Immunotherapy For The Treatment Of Mesothelioma

  June 1, 2015

   · 

  8 min read
• Drug Development

  ASCO15: Celldex Release: Randomized Phase 2 React Study Of RINTEGA In Recurrent Bevacizumab-Naive Glioblastoma Demonstrates Statistically Significant Overall Survival And Emergence Of Long-Term Survival Benefit; Primary Endpoint Of PFS6 Met

  June 1, 2015

   · 

  12 min read
• Drug Development

  ASCO15: Juno Therapeutics’s Investigational CAR T Cell Product Candidate JCAR015 Demonstrates Encouraging Clinical Responses In Patients With B-Cell Cancers

  June 1, 2015

   · 

  4 min read
• Drug Development

  Genticel Announces Positive Preclinical Proof Of Concept Results Of GTL002, Its New Multivalent HPV Therapeutic Vaccine Candidate Based On Company’s Versatile Vaxiclase Platform

  June 1, 2015

   · 

  5 min read
• Business

  MicroVention’s New SoCal Facility Will House More Than 800 Employees

  June 1, 2015

   · 

  3 min read
• Drug Development

  ASCO15: Exelixis Release:Updated Positive Results From Two Trials Of Cobimetinib In Combination With Vemurafenib For The Treatment Of Patients With Advanced Melanoma Presented At 2015 ASCO Annual Meeting

  June 1, 2015

   · 

  11 min read
• Drug Development

  Exelixis Announces Positive Results From Phase 2 Investigator-Sponsored Trial Of Cabozantinib In RET-Rearranged Non-Small Cell Lung Cancers

  June 1, 2015

   · 

  9 min read
• Drug Development

  Exelixis Announces Positive Results From Phase 2 Trial Of Cabozantinib In Patients With EGFR Wild-Type Non-Small Cell Lung Cancer

  June 1, 2015

   · 

  10 min read